High temporal resolution 3D gadolinium‐enhanced dynamic MR imaging of renal tumors with pharmacokinetic modeling: Preliminary observations

To assess dynamic contrast‐enhanced (DCE) magnetic resonance imaging (MRI) tracer pharmacokinetic parameters obtained with Generalized Kinetic Model (GKM) and extended Shutter Speed Model (SSM2) in renal tumors stratified by histologic subtypes.

[1]  Berthold Kiefer,et al.  Histogram analysis of whole-lesion enhancement in differentiating clear cell from papillary subtype of renal cell cancer. , 2012, Radiology.

[2]  Karl-Heinz Herrmann,et al.  Resolving arterial phase and temporal enhancement characteristics in DCE MRM at high spatial resolution with TWIST acquisition , 2011, Journal of magnetic resonance imaging : JMRI.

[3]  Steven P Sourbron,et al.  On the scope and interpretation of the Tofts models for DCE‐MRI , 2011, Magnetic resonance in medicine.

[4]  T. Powles,et al.  Sunitinib and other targeted therapies for renal cell carcinoma , 2011, British Journal of Cancer.

[5]  J. Patard,et al.  Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. , 2011, European urology.

[6]  J. Babb,et al.  MRI features of renal oncocytoma and chromophobe renal cell carcinoma. , 2010, AJR. American journal of roentgenology.

[7]  Aitao Guo,et al.  Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. , 2010, Radiology.

[8]  Leon Axel,et al.  Combination of Compressed Sensing and Parallel Imaging for Highly-Accelerated 3 D First-Pass Cardiac Perfusion MRI , 2009 .

[9]  J. Cheville,et al.  Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. , 2010, The Journal of urology.

[10]  Ulrike I Attenberger,et al.  Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast‐enhanced MRI: A pilot study , 2010, Journal of magnetic resonance imaging : JMRI.

[11]  Paul Russo,et al.  Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma. , 2009, The Journal of urology.

[12]  Bachir Taouli,et al.  Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. , 2009, Radiology.

[13]  Qun Chen,et al.  Optimal k‐space sampling for dynamic contrast‐enhanced MRI with an application to MR renography , 2009, Magnetic resonance in medicine.

[14]  T. Choueiri,et al.  Recent advances in the systemic treatment of metastatic papillary renal cancer , 2009, Expert review of anticancer therapy.

[15]  F. Kim,et al.  Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings , 2009 .

[16]  Harry Quon,et al.  Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast‐enhanced MRI data in squamous cell carcinoma of the head and neck , 2007, Journal of magnetic resonance imaging : JMRI.

[17]  Apurva A Desai,et al.  Sorafenib in advanced clear-cell renal-cell carcinoma. , 2007, The New England journal of medicine.

[18]  Victor E Reuter,et al.  The pathology of renal epithelial neoplasms. , 2006, Seminars in oncology.

[19]  F. Marshall,et al.  Current trends in molecular classification of adult renal tumors. , 2006, Urology.

[20]  T J Carroll,et al.  Intracranial time-resolved contrast-enhanced MR angiography at 3T. , 2006, AJNR. American journal of neuroradiology.

[21]  Xin Li,et al.  A unified magnetic resonance imaging pharmacokinetic theory: Intravascular and extracellular contrast reagents , 2005, Magnetic resonance in medicine.

[22]  J. Lam,et al.  Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. , 2005, The Journal of urology.

[23]  Wei Huang,et al.  Evidence for shutter‐speed variation in CR bolus‐tracking studies of human pathology , 2005, NMR in biomedicine.

[24]  Thomas E Yankeelov,et al.  Variation of the relaxographic “shutter‐speed” for transcytolemmal water exchange affects the CR bolus‐tracking curve shape , 2003, Magnetic resonance in medicine.

[25]  J. Cheville,et al.  Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma , 2003, The American journal of surgical pathology.

[26]  David L Buckley,et al.  Uncertainty in the analysis of tracer kinetics using dynamic contrast‐enhanced T1‐weighted MRI , 2002, Magnetic resonance in medicine.

[27]  J. Lynch,et al.  Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. , 2002, The Journal of urology.

[28]  D. Drost,et al.  Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents , 2000, Journal of magnetic resonance imaging : JMRI.

[29]  Xin Li,et al.  Equilibrium transcytolemmal water‐exchange kinetics in skeletal muscle in vivo , 1999, Magnetic resonance in medicine.

[30]  David L. Thomas,et al.  Measuring Cerebral Blood Flow Using Magnetic Resonance Imaging Techniques , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  J L Warren,et al.  Rising incidence of renal cell cancer in the United States. , 1999, JAMA.

[32]  Ting-Yim Lee,et al.  An Adiabatic Approximation to the Tissue Homogeneity Model for Water Exchange in the Brain: I. Theoretical Derivation , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[34]  P S Tofts,et al.  Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.

[35]  M. Bosniak,et al.  The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies. , 1991, Radiology.

[36]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[37]  L R Schad,et al.  Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.

[38]  G. Schwarz.  Estimating the Dimension of a Model , 1978 .

[39]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..